{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:17:19Z","timestamp":1771834639245,"version":"3.50.1"},"reference-count":19,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2025.2025.0356","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:32:11Z","timestamp":1762770731000},"source":"Crossref","is-referenced-by-count":0,"title":["Salvage Treatment Options for Post-Transplant Relapse in Children with Early\/Very Early Relapse of Acute Lymphoblastic Leukemia: A Single Center Experience"],"prefix":"10.4274","author":[{"given":"Z\u00fchre","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap Kirkiz","family":"Kayal\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Bayraml\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine Y\u0131lmaz","family":"Orulluo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dclker","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s11912-024-01608-4","article-title":"Paediatric acute lymphoblastic leukaemia: a narrative review of current knowledge and advancements","volume":"26","author":"Elgazar","year":"2024","unstructured":"1. Elgazar S, Constantinou C. Paediatric acute lymphoblastic leukaemia: a narrative review of current knowledge and advancements. Curr Oncol Rep. 2024;26:1586-1599.","journal-title":"Curr Oncol Rep"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood.2019004043","article-title":"How I treat relapsed acute lymphoblastic leukemia in the pediatric population","volume":"136","author":"SP","year":"2020","unstructured":"2. Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 2020;136:1803-1812.","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12098-023-04635-4","article-title":"Relapsed acute lymphoblastic leukemia","volume":"91","author":"Sidhu","year":"2024","unstructured":"3. Sidhu J, Gogoi MP, Krishnan S, Saha V. Relapsed acute lymphoblastic leukemia. Indian J Pediatr. 2024;91:158-167.","journal-title":"Indian J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Y\u0131lmaz Bengoa \u015e, Ataseven E, K\u0131zmazo\u011flu D, Demir Yenig\u00fcrb\u00fcz F, Erdem M, \u00d6ren H. FLAG regimen with or without idarubicin in children with relapsed\/refractory acute leukemia: experience from a Turkish pediatric hematology center. Turk J Hematol. 2017;34:46-51.","DOI":"10.4274\/Tjh.2015.0411"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Ayg\u00fcne\u015f U, Karag\u00fcn B\u015e, \u015ea\u015fmaz I, Antmen AB. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: a single-center experience. Clin Transplant. 2024;38:e15366.","DOI":"10.1111\/ctr.15366"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1007\/s12325-023-02696-7","article-title":"Patient-level meta-analysis of clofarabine in acute lymphoblastic leukemia","volume":"40","author":"Jeha","year":"2023","unstructured":"6. Jeha S, Goto H, Baruchel A, Bo\u00eblle-Le Corfec E, Geffriaud-Ricouard C, Pieters R, Shin HY. Patient-level meta-analysis of clofarabine in acute lymphoblastic leukemia. Adv Ther. 2023;40:5447-5463.","journal-title":"Adv Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/bmt.2016.224","article-title":"Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience","volume":"52","author":"Willasch","year":"2017","unstructured":"7. Willasch AM, Salzmann-Manrique E, Krenn T, Duerken M, Faber J, Opper J, Kreyenberg H, Bager R, Huenecke S, Cappel C, Bremm M, Pfirrmann V, Merker M, Ullrich E, Bakhtiar S, Rettinger E, Jarisch A, Soerensen J, Klingebiel TE, Bader P. Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience. Bone Marrow Transplant. 2017;52:201-208.","journal-title":"Bone Marrow Transplant"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","unstructured":"8. Parker WB. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev. 2009;109:2880-2893.","journal-title":"Chem Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/ped.12837","article-title":"Childhood relapsed acute lymphoblastic leukemia: biology and recent treatment progress","volume":"57","author":"Goto","year":"2015","unstructured":"9. Goto H. Childhood relapsed acute lymphoblastic leukemia: biology and recent treatment progress. Pediatr Int. 2015;57:1059-1066.","journal-title":"Pediatr Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bjh.14505","article-title":"The combination of bortezomib with chemotherapy to treat relapsed\/refractory acute lymphoblastic leukemia of childhood","volume":"176","author":"Bertaina","year":"2017","unstructured":"10. Bertaina A, Vinti L, Strocchio L, Gaspari S, Caruso R, Algeri M, Coletti V, Gurnari C, Romano M, Cefalo MG, Girardi K, Trevisan V, Bertaina V, Merli P, Locatelli F. The combination of bortezomib with chemotherapy to treat relapsed\/refractory acute lymphoblastic leukemia of childhood. Br J Haematol. 2017;176:629-636.","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/bjh.15919","article-title":"Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group","volume":"186","author":"Horton","year":"2019","unstructured":"11. Horton TM, Whitlock JA, Lu X, O'Brien MM, Borowitz MJ, Devidas M, Raetz EA, Brown PA, Carroll WL, Hunger SP. Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group. Br J Haematol. 2019;186:274-285.","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jtct.2023.10.024","article-title":"Blinatumomab therapy is associated with favorable outcomes after allogeneic hematopoietic cell transplantation in pediatric patients with B cell acute lymphoblastic leukemia","volume":"30","author":"Llaurador","year":"2024","unstructured":"12. Llaurador G, Shaver K, Wu M, Wang T, Gillispie A, Doherty E, Craddock J, Read J, Yassine K, Morales E, George A, Steffin D, Krance R, Martinez C, Heslop H, Salem B. Blinatumomab therapy is associated with favorable outcomes after allogeneic hematopoietic cell transplantation in pediatric patients with B cell acute lymphoblastic leukemia. Transplant Cell Ther. 2024;30:217-227.","journal-title":"Transplant Cell Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2422151","DOI":"10.1080\/16078454.2024.2422151","article-title":"Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis","volume":"29","author":"Guo","year":"2024","unstructured":"13. Guo HP, Liu Y, Kang L, Liu C, Qin WW. Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis. Hematology. 2024;29:2422151.","journal-title":"Hematology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"605766","DOI":"10.3389\/fimmu.2021.605766","article-title":"Integrating CAR T-cell therapy and transplantation: comparisons of safety and long-term efficacy of allogeneic hematopoietic stem cell transplantation after CAR T-cell or chemotherapy-based complete remission in B-cell acute lymphoblastic leukemia","volume":"12","author":"Zhao","year":"2021","unstructured":"14. Zhao YL, Liu DY, Sun RJ, Zhang JP, Zhou JR, Wei ZJ, Xiong M, Cao XY, Lu Y, Yang JF, Zhang X, Lu DP, Lu P. Integrating CAR T-cell therapy and transplantation: comparisons of safety and long-term efficacy of allogeneic hematopoietic stem cell transplantation after CAR T-cell or chemotherapy-based complete remission in B-cell acute lymphoblastic leukemia. Front Immunol. 2021;12:605766.","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/08880018.2011.629859","article-title":"ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center","volume":"29","author":"Kocak","year":"2012","unstructured":"15. Kocak U, Gursel T, Kaya Z, Aral YZ, Albayrak M, Keskin EY, Belen B, Is\u0131k M, Oner N. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. Pediatr Hematol Oncol. 2012;29:130-140.","journal-title":"Pediatr Hematol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.pediatrneurol.2015.03.006","article-title":"Acute central nervous system complications in pediatric acute lymphoblastic leukemia","volume":"53","author":"Baytan","year":"2015","unstructured":"16. Baytan B, Evim MS, G\u00fcler S, G\u00fcne\u015f AM, Okan M. Acute central nervous system complications in pediatric acute lymphoblastic leukemia. Pediatr Neurol. 2015;53:312-318.","journal-title":"Pediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41375-024-02474-6","article-title":"Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study","volume":"39","author":"Argyriadi","year":"2025","unstructured":"17. Argyriadi EA, Steffen IG, Chen-Santel C, Lissat A, Attarbaschi A, Bourquin JP, Henze G, von Stackelberg A. Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study. Leukemia. 2025;39:337-345.","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. T\u00fcfek\u00e7i \u00d6, Evim MS, G\u00fcne\u015f AM, Celkan T, Karapinar DY, Kaya Z, Baysal B, Baytan B, Ko\u00e7ak \u00dc, Yilmaz \u015e, \u00c7inar S, \u00d6ren H. Assessment of minimal residual disease in childhood acute lymphoblastic leukemia: a multicenter study from Turkey. J Pediatr Hematol Oncol. 2022;44:e396-e402.","DOI":"10.1097\/MPH.0000000000002419"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2141.2008.07499.x","article-title":"Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-M\u00fcnster (BFM) Study Group","volume":"144","author":"Reism\u00fcller B","year":"2009","unstructured":"19. Reism\u00fcller B, Attarbaschi A, Peters C, Dworzak MN, P\u00f6tschger U, Urban C, Fink FM, Meister B, Schmitt K, Dieckmann K, Henze G, Haas OA, Gadner H, Mann G; Austrian Berlin-Frankfurt-M\u00fcnster (BFM) Study Group. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-M\u00fcnster (BFM) Study Group. Br J Haematol. 2009;144:559-570.","journal-title":"Br J Haematol"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:48:56Z","timestamp":1771832936000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-95867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2025.2025.0356","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}